In the report regarding the product licence application of the Antihemophilic Factor, it was noted that the donors met the criteria of the regulations and each was tested for syphilis. The medical assessor also added that there had been no inspection of the manufacturing facilities.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates
Key Person(s)
Dr Duncan P Thomas